Saturday, April 05, 2014 1:49:08 PM
Mcet is the most advanced biotech company which uses mrna technology to cure liver cancer. If they can show similar results in phase 2b as in phase 2a, Pfizer will buy them out for at least .3000 dollar/share (1-1.5 billion dollar). For now a fair value is 10% of that, worth .0300 dollar/share.
Sentiment: Strong Buy
Good post from the Yahoo Finance board.
http://finance.yahoo.com/mbview/threadview/?&bn=ab116216-adca-32a3-b056-c6907bc35e82&tid=1396697142711-3dfb554b-1ad9-4d41-8426-42408c10274b&tls=la%2Cd%2C0%2C3
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM